NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus. (Q51372617)

4 April 2018

title

NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus. (English)

1 reference

4 April 2018

1 reference

12

Zhao-Qian Liu

1 reference

4 April 2018

Fei-Feng Sheng

1

1 reference

4 April 2018

Xing-Ping Dai

2

1 reference

4 April 2018

Jian Qu

3

1 reference

4 April 2018

Guang-Hua Lei

4

1 reference

4 April 2018

Hong-Bin Lu

5

1 reference

4 April 2018

Jing Wu

6

1 reference

4 April 2018

Xiao-Jing Xu

7

1 reference

4 April 2018

Qi Pei

8

1 reference

4 April 2018

Min Dong

9

1 reference

4 April 2018

Ying-Zi Liu

10

1 reference

4 April 2018

Hong-Hao Zhou

11

1 reference

4 April 2018

publication date

1 August 2011

1 reference

4 April 2018

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

4 April 2018

volume

38

1 reference

4 April 2018

page(s)

550-554

1 reference

4 April 2018

issue

8

1 reference

4 April 2018

The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Functional aspects of protein mono-ADP-ribosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2011.05548.X

10.1111/J.1440-1681.2011.05548.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

21631570

1 reference

4 April 2018